Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13820265 | 0.79 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL1524030 | 0.76 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL549021 | 0.76 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL15922930 | 0.76 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL16566251 | 0.75 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL14953127 | 0.74 | HSD11B1 (0.37) | ALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL5017321 | 0.74 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL29078864 | 0.74 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL10546677 | 0.73 | GBA1 (0.35) | GBA1GAA | |
| SCHEMBL15923054 | 0.72 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017559-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-01-20 | — | — | US | disclosed |
| US-11014955-B2 | Cyclic peroxides as prodrugs for selective delivery of agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-05-25 | — | — | US | disclosed |
| US-20200317714-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-10-08 | — | — | US | disclosed |
| US-10662215-B2 | Cyclic peroxides as prodrugs for selective delivery of agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-05-26 | — | — | US | disclosed |
| US-20190284224-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-09-19 | — | — | US | disclosed |
| US-10287312-B2 | Cyclic peroxides as prodrugs for selective delivery of agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-05-14 | — | — | US | disclosed |
| EP-3104857-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | The Regents of The University of California (US) | 2016-12-21 | — | — | EP | disclosed |
| US-20160362439-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-12-15 | — | — | US | disclosed |
| WO-2015123595-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662215-B2 | Cyclic peroxides as prodrugs for selective delivery of agents | GPX4, PRDX1, PRDX3 | ALDH1A1 135/4885SMN1; SMN2 991/4885HSD11B1 523/4885 |
| US-11014955-B2 | Cyclic peroxides as prodrugs for selective delivery of agents | GPX4, PRDX1, PRDX3 | ALDH1A1 135/4885SMN1; SMN2 991/4885HSD11B1 523/4885 |
| US-20190284224-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | GPX4, PRDX1, PRDX3 | ALDH1A1 135/4885SMN1; SMN2 991/4885HSD11B1 523/4885 |
| US-20220017559-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | GPX4, PRDX1, PRDX3 | ALDH1A1 135/4885SMN1; SMN2 991/4885HSD11B1 523/4885 |
| US-20160362439-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | GPX4, PRDX1, PRDX3 | ALDH1A1 135/4885SMN1; SMN2 991/4885HSD11B1 523/4885 |
| US-10287312-B2 | Cyclic peroxides as prodrugs for selective delivery of agents | GPX4, PRDX1, PRDX3 | ALDH1A1 135/4885SMN1; SMN2 991/4885HSD11B1 523/4885 |
| US-20200317714-A1 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | GPX4, PRDX1, GPX1 | ALDH1A1 256/4885SMN1; SMN2 1026/4885HSD11B1 458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.